2012
DOI: 10.1016/j.jhep.2011.12.018
|View full text |Cite
|
Sign up to set email alerts
|

A novel biliary stent loaded with 125I seeds in patients with malignant biliary obstruction: Preliminary results versus a conventional biliary stent

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
86
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 90 publications
(90 citation statements)
references
References 35 publications
2
86
0
Order By: Relevance
“…Some researches has shown that peform PTBS for patients with malignant obstructive jaundice combined with anti-tumor treatment could significantly prolong stent patency and survival time (Qian et al, 2006). This study shows that the mean reobstructiive time in combination group is 125 days, significantly longer (Todoroki T et al, 2000;Simmons et al, 2006;Zhu et al, 2012). Interventional drainage in the treatment of the obstructive jaundice caused by recurrence and metastasis after tumor resection can decrease bilirubin level quickly in a short period and promote the liver function recovery.…”
Section: Discussionmentioning
confidence: 79%
“…Some researches has shown that peform PTBS for patients with malignant obstructive jaundice combined with anti-tumor treatment could significantly prolong stent patency and survival time (Qian et al, 2006). This study shows that the mean reobstructiive time in combination group is 125 days, significantly longer (Todoroki T et al, 2000;Simmons et al, 2006;Zhu et al, 2012). Interventional drainage in the treatment of the obstructive jaundice caused by recurrence and metastasis after tumor resection can decrease bilirubin level quickly in a short period and promote the liver function recovery.…”
Section: Discussionmentioning
confidence: 79%
“…Zhu et al . [6] were the first to report encouraging results with its clinical application. However, seed activity, reference point of prescription dose, and the irradiation dose of target were different in the related studies.…”
Section: Introductionmentioning
confidence: 99%
“…Zhu et al [19] found no incidence of stent migration when they treated biliary malignancy with intraluminal radiotherapy, but this may be due to their use of a stent-in-stent configuration. Engineer et al [13] concluded that endobiliary stents were stable tumour surrogates during EBRT after they found population mean position changes of less than 0.4 cm in all directions during EBRT.…”
Section: Discussionmentioning
confidence: 99%